Bacteria in aquatic environment can modulate the ability of adult mosquitoes to transmit human pathogens

Mosquitoes are holometabolous insects (i.e. organisms that go through a complete metamorphosis). As such, they occupy two main habitats during their life cycle. The larval stage develops in water and the adult stage lives on land. The adult traits of mosquitoes (e.g. body size, lifespan, susceptibility to human pathogens) depend on environmental conditions experienced both during larval development and during adult life.

Recently, the scientific community has realized that the adult mosquito gut microbiota (the microbes that are living in the gut of the mosquito) contributes to modulate the transmission of mosquito-borne pathogens. However, the role of the microbiota of larvae in influencing adult traits has remained under explored.

This question is particularly important for Aedes aegypti, a major vector of arboviruses such as dengue, yellow fever, Zika and chikungunya viruses. In sub-Saharan Africa, Ae. aegypti exists in an urban form and a forest form, and the larval breeding sites differ between the two. Whereas the urban form develops in man-made containers such as used tires and discarded items, the forest form develops in natural breeding sites such as rock pools and tree holes.

Researchers from the Institut Pasteur and CNRS, in collaboration with scientific teams from IRD, University Claude Bernard Lyon 1, and CIRMF in Gabon, observed differences in the gut microbiota of Ae. aegypti larvae breeding in the forest or in the urban environment. Back to the lab, they demonstrated that differential bacterial exposure during the development of Ae. aegypti larvae can have "carry-over" effects on adult traits related to a mosquito's ability to be a successful vector of arboviruses. Thus, exposure to different bacteria during development results in variation in the speed at which that larvae develop, the size of adult mosquitoes, immune activity of adults, as well as susceptibility to dengue virus.

As explained by Laura Dickson, first author of the study and researcher at the Institut Pasteur, "this discovery is highly significant because it provides the first empirical proof of principle that bacteria in the aquatic environment can modulate the ability of adult mosquitoes to transmit human pathogens." According to Louis Lambrechts, researcher at CNRS, head of the Insect-Virus Interactions group at the Institut Pasteur and coordinator of the study, "our discovery calls for an increased appreciation of the role of larval ecology in the transmission of mosquito-borne pathogens."

These findings represent an important first step toward a more comprehensive understanding of how the environment shapes the risk of vector-borne disease. Improved knowledge on the bacteria found in natural larval breeding sites and their consequence at the adult stage could lead to new disease control strategies. For instance, this could be done by targeting the breeding sites where mosquito larvae are most likely to become efficient vectors of arboviruses. An alternative could be to directly manipulate the bacteria in breeding sites to reduce the ability of mosquitoes emerging from these sites to transmit human pathogens.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research suggests no need for yellow fever vaccine booster after initial dose